US Stock MarketDetailed Quotes

BriaCell Therapeutics (BCTX)

Watchlist
  • 3.880
  • +0.150+4.02%
Close Apr 24 16:00 ET
  • 3.953
  • +0.073+1.89%
Post 20:01 ET
28.13MMarket Cap-0.27P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

BriaCell Therapeutics (BCTX) Balance Sheet

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jan 31, 2026
(Q1)Oct 31, 2025
(FY)Jul 31, 2025
(Q4)Jul 31, 2025
(Q3)Apr 30, 2025
(Q2)Jan 31, 2025
(Q1)Oct 31, 2024
(FY)Jul 31, 2024
(Q4)Jul 31, 2024
(Q3)Apr 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments
496.44%29.9M
75.68%10.18M
1,972.44%17.87M
1,972.44%17.87M
1,231.66%12.46M
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-Cash and cash equivalents
496.44%29.9M
-53.14%2.71M
1,117.25%10.49M
1,117.25%10.49M
1,231.66%12.46M
-19.71%5.01M
-57.55%5.79M
-95.94%862.09K
-95.94%862.09K
-96.68%935.69K
-Short-term investments
--0
--7.46M
--7.37M
--7.37M
----
----
----
--0
--0
----
Receivables
5.88%2.28M
-51.69%1.17M
-58.74%564.79K
-58.74%564.79K
15,162.55%2.32M
7,028.61%2.15M
11,235.03%2.43M
90.74%1.37M
90.74%1.37M
2.26%15.23K
-Accounts receivable
5.88%2.28M
-51.69%1.17M
----
----
15,162.55%2.32M
7,028.61%2.15M
11,235.03%2.43M
----
----
2.26%15.23K
-Other receivables
----
----
-58.74%564.79K
-58.74%564.79K
----
----
----
90.74%1.37M
90.74%1.37M
----
Prepaid assets
----
----
5.11%1.5M
5.11%1.5M
----
----
----
-71.43%1.42M
-71.43%1.42M
247.43%4.58M
Total current assets
349.26%32.18M
38.07%11.35M
445.36%19.93M
445.36%19.93M
167.36%14.79M
-39.00%7.16M
-55.35%8.22M
-86.44%3.65M
-86.44%3.65M
-81.26%5.53M
Non current assets
Net PPE
-26.67%251.14K
-25.01%273.98K
-23.53%296.82K
-23.53%296.82K
--319.66K
--342.5K
--365.34K
--388.18K
--388.18K
----
-Gross PPE
----
----
0.00%456.8K
0.00%456.8K
----
----
----
--456.8K
--456.8K
----
-Accumulated depreciation
----
----
-133.12%-159.98K
-133.12%-159.98K
----
----
----
---68.63K
---68.63K
----
Goodwill and other intangible assets
-7.95%176.89K
-7.79%180.71K
-7.64%184.53K
-7.64%184.53K
-7.50%188.34K
-7.36%192.16K
-7.23%195.98K
-7.10%199.8K
-7.10%199.8K
-6.98%203.61K
-Other intangible assets
----
----
-7.64%184.53K
-7.64%184.53K
----
----
----
-7.10%199.8K
-7.10%199.8K
----
Investments and advances
28.18%582.46K
31.39%554.45K
25.28%524.28K
25.28%524.28K
5.75%496.65K
61.33%454.39K
21,098,650.00%421.98K
20,924,400.00%418.49K
20,924,400.00%418.49K
23,482,900.00%469.66K
Non current prepaid assets
-66.58%405.09K
-40.80%717.51K
-40.80%717.51K
-40.80%717.51K
--1.21M
--1.21M
--1.21M
--1.21M
--1.21M
----
Total non current assets
-35.68%1.42M
-21.35%1.73M
-22.33%1.72M
-22.33%1.72M
229.23%2.22M
350.02%2.2M
939.15%2.2M
931.48%2.22M
931.48%2.22M
207.59%673.27K
Total assets
258.78%33.59M
25.55%13.08M
268.68%21.65M
268.68%21.65M
174.08%17M
-23.44%9.36M
-44.07%10.41M
-78.38%5.87M
-78.38%5.87M
-79.13%6.2M
Liabilities
Current liabilities
Payables
-62.43%1.88M
-49.72%2.13M
-54.21%3.28M
-54.21%3.28M
-48.94%3.28M
34.81%5M
875.76%4.23M
538.12%7.17M
538.12%7.17M
545.30%6.42M
-accounts payable
-62.43%1.88M
-49.72%2.13M
-54.21%3.28M
-54.21%3.28M
-48.94%3.28M
34.81%5M
875.76%4.23M
538.12%7.17M
538.12%7.17M
545.30%6.42M
Current accrued expenses
473.77%1.31M
57.53%1.19M
139.10%694.29K
139.10%694.29K
213.53%1.05M
6.92%227.6K
23.19%754.67K
-57.15%290.38K
-57.15%290.38K
-13.53%335.36K
Current liabilities
-39.10%3.19M
-33.49%3.32M
-46.68%3.98M
-46.68%3.98M
-35.92%4.33M
33.29%5.23M
376.69%4.99M
314.17%7.46M
314.17%7.46M
388.60%6.76M
Non current liabilities
Derivative product liabilities
-78.46%195.1K
-76.24%406.87K
-69.19%337.67K
-69.19%337.67K
-87.14%730.01K
-94.55%905.84K
-88.62%1.71M
-96.24%1.1M
-96.24%1.1M
-83.41%5.68M
Total non current liabilities
-78.46%195.1K
-76.24%406.87K
-69.19%337.67K
-69.19%337.67K
-87.14%730.01K
-94.55%905.84K
-88.62%1.71M
-96.24%1.1M
-96.24%1.1M
-83.41%5.68M
Total liabilities
-44.91%3.38M
-44.42%3.72M
-49.57%4.32M
-49.57%4.32M
-59.31%5.06M
-70.14%6.14M
-58.38%6.7M
-72.34%8.56M
-72.34%8.56M
-65.08%12.44M
Shareholders'equity
Share capital
37.06%117.12M
24.01%101.74M
40.98%101.74M
40.98%101.74M
35.11%94.02M
22.79%85.45M
17.89%82.04M
3.70%72.17M
3.70%72.17M
6.10%69.59M
-common stock
37.06%117.12M
24.01%101.74M
40.98%101.74M
40.98%101.74M
35.11%94.02M
22.79%85.45M
17.89%82.04M
3.70%72.17M
3.70%72.17M
6.10%69.59M
Retained earnings
-30.39%-127.17M
-31.46%-119.95M
-30.79%-111.76M
-30.79%-111.76M
-23.07%-103.66M
-13.49%-97.54M
-22.23%-91.25M
-5.94%-85.44M
-5.94%-85.44M
-7.66%-84.23M
Gains losses not affecting retained earnings
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
0.00%-138.68K
Other equity interest
159.75%41.11M
111.63%28.33M
154.09%28.04M
154.09%28.04M
151.90%22.2M
88.00%15.83M
--13.39M
48.66%11.03M
48.66%11.03M
--8.81M
Total stockholders'equity
758.09%30.92M
146.82%9.98M
850.54%17.88M
850.54%17.88M
308.13%12.42M
144.63%3.6M
48.55%4.04M
36.93%-2.38M
36.93%-2.38M
-1.23%-5.97M
Noncontrolling interests
-86.85%-702.63K
-90.39%-627.56K
-80.75%-546.8K
-80.75%-546.8K
-76.93%-474.06K
-53.85%-376.03K
-60.70%-329.62K
---302.52K
---302.52K
---267.94K
Total equity
836.31%30.21M
151.83%9.35M
745.60%17.33M
745.60%17.33M
291.58%11.94M
138.80%3.23M
47.56%3.71M
28.92%-2.68M
28.92%-2.68M
-5.78%-6.23M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jan 31, 2026(Q1)Oct 31, 2025(FY)Jul 31, 2025(Q4)Jul 31, 2025(Q3)Apr 30, 2025(Q2)Jan 31, 2025(Q1)Oct 31, 2024(FY)Jul 31, 2024(Q4)Jul 31, 2024(Q3)Apr 30, 2024
Assets
Current assets
Cash, cash equivalents and short term investments 496.44%29.9M75.68%10.18M1,972.44%17.87M1,972.44%17.87M1,231.66%12.46M-19.71%5.01M-57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K
-Cash and cash equivalents 496.44%29.9M-53.14%2.71M1,117.25%10.49M1,117.25%10.49M1,231.66%12.46M-19.71%5.01M-57.55%5.79M-95.94%862.09K-95.94%862.09K-96.68%935.69K
-Short-term investments --0--7.46M--7.37M--7.37M--------------0--0----
Receivables 5.88%2.28M-51.69%1.17M-58.74%564.79K-58.74%564.79K15,162.55%2.32M7,028.61%2.15M11,235.03%2.43M90.74%1.37M90.74%1.37M2.26%15.23K
-Accounts receivable 5.88%2.28M-51.69%1.17M--------15,162.55%2.32M7,028.61%2.15M11,235.03%2.43M--------2.26%15.23K
-Other receivables ---------58.74%564.79K-58.74%564.79K------------90.74%1.37M90.74%1.37M----
Prepaid assets --------5.11%1.5M5.11%1.5M-------------71.43%1.42M-71.43%1.42M247.43%4.58M
Total current assets 349.26%32.18M38.07%11.35M445.36%19.93M445.36%19.93M167.36%14.79M-39.00%7.16M-55.35%8.22M-86.44%3.65M-86.44%3.65M-81.26%5.53M
Non current assets
Net PPE -26.67%251.14K-25.01%273.98K-23.53%296.82K-23.53%296.82K--319.66K--342.5K--365.34K--388.18K--388.18K----
-Gross PPE --------0.00%456.8K0.00%456.8K--------------456.8K--456.8K----
-Accumulated depreciation ---------133.12%-159.98K-133.12%-159.98K---------------68.63K---68.63K----
Goodwill and other intangible assets -7.95%176.89K-7.79%180.71K-7.64%184.53K-7.64%184.53K-7.50%188.34K-7.36%192.16K-7.23%195.98K-7.10%199.8K-7.10%199.8K-6.98%203.61K
-Other intangible assets ---------7.64%184.53K-7.64%184.53K-------------7.10%199.8K-7.10%199.8K----
Investments and advances 28.18%582.46K31.39%554.45K25.28%524.28K25.28%524.28K5.75%496.65K61.33%454.39K21,098,650.00%421.98K20,924,400.00%418.49K20,924,400.00%418.49K23,482,900.00%469.66K
Non current prepaid assets -66.58%405.09K-40.80%717.51K-40.80%717.51K-40.80%717.51K--1.21M--1.21M--1.21M--1.21M--1.21M----
Total non current assets -35.68%1.42M-21.35%1.73M-22.33%1.72M-22.33%1.72M229.23%2.22M350.02%2.2M939.15%2.2M931.48%2.22M931.48%2.22M207.59%673.27K
Total assets 258.78%33.59M25.55%13.08M268.68%21.65M268.68%21.65M174.08%17M-23.44%9.36M-44.07%10.41M-78.38%5.87M-78.38%5.87M-79.13%6.2M
Liabilities
Current liabilities
Payables -62.43%1.88M-49.72%2.13M-54.21%3.28M-54.21%3.28M-48.94%3.28M34.81%5M875.76%4.23M538.12%7.17M538.12%7.17M545.30%6.42M
-accounts payable -62.43%1.88M-49.72%2.13M-54.21%3.28M-54.21%3.28M-48.94%3.28M34.81%5M875.76%4.23M538.12%7.17M538.12%7.17M545.30%6.42M
Current accrued expenses 473.77%1.31M57.53%1.19M139.10%694.29K139.10%694.29K213.53%1.05M6.92%227.6K23.19%754.67K-57.15%290.38K-57.15%290.38K-13.53%335.36K
Current liabilities -39.10%3.19M-33.49%3.32M-46.68%3.98M-46.68%3.98M-35.92%4.33M33.29%5.23M376.69%4.99M314.17%7.46M314.17%7.46M388.60%6.76M
Non current liabilities
Derivative product liabilities -78.46%195.1K-76.24%406.87K-69.19%337.67K-69.19%337.67K-87.14%730.01K-94.55%905.84K-88.62%1.71M-96.24%1.1M-96.24%1.1M-83.41%5.68M
Total non current liabilities -78.46%195.1K-76.24%406.87K-69.19%337.67K-69.19%337.67K-87.14%730.01K-94.55%905.84K-88.62%1.71M-96.24%1.1M-96.24%1.1M-83.41%5.68M
Total liabilities -44.91%3.38M-44.42%3.72M-49.57%4.32M-49.57%4.32M-59.31%5.06M-70.14%6.14M-58.38%6.7M-72.34%8.56M-72.34%8.56M-65.08%12.44M
Shareholders'equity
Share capital 37.06%117.12M24.01%101.74M40.98%101.74M40.98%101.74M35.11%94.02M22.79%85.45M17.89%82.04M3.70%72.17M3.70%72.17M6.10%69.59M
-common stock 37.06%117.12M24.01%101.74M40.98%101.74M40.98%101.74M35.11%94.02M22.79%85.45M17.89%82.04M3.70%72.17M3.70%72.17M6.10%69.59M
Retained earnings -30.39%-127.17M-31.46%-119.95M-30.79%-111.76M-30.79%-111.76M-23.07%-103.66M-13.49%-97.54M-22.23%-91.25M-5.94%-85.44M-5.94%-85.44M-7.66%-84.23M
Gains losses not affecting retained earnings 0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K0.00%-138.68K
Other equity interest 159.75%41.11M111.63%28.33M154.09%28.04M154.09%28.04M151.90%22.2M88.00%15.83M--13.39M48.66%11.03M48.66%11.03M--8.81M
Total stockholders'equity 758.09%30.92M146.82%9.98M850.54%17.88M850.54%17.88M308.13%12.42M144.63%3.6M48.55%4.04M36.93%-2.38M36.93%-2.38M-1.23%-5.97M
Noncontrolling interests -86.85%-702.63K-90.39%-627.56K-80.75%-546.8K-80.75%-546.8K-76.93%-474.06K-53.85%-376.03K-60.70%-329.62K---302.52K---302.52K---267.94K
Total equity 836.31%30.21M151.83%9.35M745.60%17.33M745.60%17.33M291.58%11.94M138.80%3.23M47.56%3.71M28.92%-2.68M28.92%-2.68M-5.78%-6.23M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +16.17%
Sample Name
Sample Code
 +12.91%
Sample Name
Sample Code
 +12.09%
4
VanEck Oil Services ETF
OIH
+5.81%
5
ProShares Ultra Bloomberg Crude Oil ETF
UCO
+4.91%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +12.90%
Sample Name
Sample Code
 +11.93%
Sample Name
Sample Code
 +8.63%
4
United Microelectronics
UMC
+5.32%
5
Chagee Holdings
CHA
+3.37%
View More
Middle East conflict spreads to the stock market! How should investors respond?
Signs of restarting the second round of US-Iran talks have emerged. According to reports, Iran's foreign minister arrived in Pakistan on Fri Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -